Success in Controlling Outbreaks in an ICU Using CDC Toolkit Interventions

Article

Infections due to carbapenem-resistant Enterobacteriaceae (CRE) are on the rise globally. On the CDC’s Safe Healthcare Blog, Dr. Kyle Enfield, assistant hospital epidemiologist and medical director of the Medical Intensive Care Unit at the University of Virginia Health System, describes how his team implemented infection control interventions to assess the prevalence of CRE and extensively drug-resistant Acinetobacter baumannii in the unit. This set of interventions became recommended practice in the CDC’s 2012 Carbapenem-resistant Enterobacteriaceae Toolkit.

As a result, the CRE incidence came down to 0.1 percent of patient days and drug-resistant A. baumannii was eliminated in the unit. These findings were published in the July 2014 issue of Infection Control and Hospital Epidemiology.

Has your facility implemented the CRE Toolkit? Let the CDC know by posting a comment on the Safe Healthcare Blog.



Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content